Sign in or register to see full information and data.

Studies / CAVD 485


Study information

Grant Affiliation:Walker: bNabs after Infection and Immunization
Strategy:Prophylactic neutralizing Ab
Study Type:Antibody Screening
Species:Non-Organism Study
Stage:Assays Completed
Study Start Date:2015-04-02
Study Made Public:2016-02-16


Tier 1 and Tier 2 neutralization evaluation of plasma samples from 47 HIV+ individuals from an clinical HIV-1 observation cohort in Germany


CAVD 485 is an immunogenicity study of broadly neutralizing antibodies.


No Products used in study

Integrated data

No integrated data is available for this study.

Non-integrated data

No non-integrated data is available for this study.